ConductScience.org, home

Paper41228299

Antigenic Dark Matter: Unexplored Post-Translational Modifications of Tumor-Associated and Tumor-Specific Antigens in Pancreatic Cancer.

Safa A and 3 others. Cancers (Basel), 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Antigenic Dark Matter: Unexplored Post-Translational Modifications of Tumor-Associated and Tumor-Specific Antigens in Pancreatic Cancer. Papers, record 41228299. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41228299

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antigenic Dark Matter: Unexplored Post-Translational Modifications of Tumor-Associated and Tumor-Specific Antigens in Pancreatic Cancer.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.31, provisional
iCite
Revised in PubMed
2026-09-25
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Safa AAmin
2Vruzhaj IIdrishttps://orcid.org/0000-0002-9709-1169
3Gambirasi MMartahttps://orcid.org/0009-0007-4140-5521
4Toffoli GGiuseppehttps://orcid.org/0000-0002-5323-4762

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Italian Ministry of Health (Ricerca Corrente)Italian Ministry of Health (Ricerca Corrente)PubMed

Source PubMed

Download CSV of grants

References250

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134267656Efficacy and Safety of Anti-PD-1/ PD-L1 Monotherapy for Metastatic Breast Cancer: Clinical Evidence.Front Pharmacol2021https://conductscience.org/library/papers/34267656PubMed
215937340Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.J Biol Chem2005https://conductscience.org/library/papers/15937340PubMed
339752908ENO1 promotes PDAC progression by inhibiting CD8+ T cell infiltration through upregulating PD-L1 expression via HIF-1α signaling.Transl Oncol2025https://conductscience.org/library/papers/39752908PubMed
439043656The molecular basis underlying T cell specificity towards citrullinated epitopes presented by HLA-DR4.Nat Commun2024https://conductscience.org/library/papers/39043656PubMed
537346044Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells.Front Immunol2023https://conductscience.org/library/papers/37346044PubMed
634106045Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment.Elife2021https://conductscience.org/library/papers/34106045PubMed
724605112The emerging immunological role of post-translational modifications by reactive nitrogen species in cancer microenvironment.Front Immunol2014https://conductscience.org/library/papers/24605112PubMed
837643018ST6GAL1 sialyltransferase promotes acinar to ductal metaplasia and pancreatic cancer progression.JCI Insight2023https://conductscience.org/library/papers/37643018PubMed
937500632MSBooster: improving peptide identification rates using deep learning-based features.Nat Commun2023https://conductscience.org/library/papers/37500632PubMed
1036365233PAD4 and Its Inhibitors in Cancer Progression and Prognosis.Pharmaceutics2022https://conductscience.org/library/papers/36365233PubMed
1136612133Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies.Cancers (Basel)2022https://conductscience.org/library/papers/36612133PubMed
1237550801ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.J Pathol2023https://conductscience.org/library/papers/37550801PubMed
1332226930Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects.Chronic Dis Transl Med2020https://conductscience.org/library/papers/32226930PubMed
1435533046Cancer-associated fibroblasts in pancreatic cancer: new subtypes, new markers, new targets.J Pathol2022https://conductscience.org/library/papers/35533046PubMed
1536104770O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy.Mol Med2022https://conductscience.org/library/papers/36104770PubMed
1636543135β-hydroxybutyrate inhibits ferroptosis-mediated pancreatic damage in acute liver failure through the increase of H3K9bhb.Cell Rep2022https://conductscience.org/library/papers/36543135PubMed
1737143582Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications.MedComm (2020)2023https://conductscience.org/library/papers/37143582PubMed
1840790272Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final results.Nat Med2025https://conductscience.org/library/papers/40790272PubMed
1937353482Molecular mechanism of phosphopeptide neoantigen immunogenicity.Nat Commun2023https://conductscience.org/library/papers/37353482PubMed
2035626033Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes.Cancers (Basel)2022https://conductscience.org/library/papers/35626033PubMed

See all 250 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42983511Pan-modification proteomics: decoding tumor heterogeneity and guiding the next generation of precision oncology.Cancer Cell Int2026https://conductscience.org/library/papers/42983511PubMed
42681683Advances, challenges, and innovative strategies of CAR-T cell therapy in pancreatic cancer.Biomark Res2026https://conductscience.org/library/papers/42681683PubMed
42657027Phosphorylation shapes antigen presentation and immune recognition: mechanistic insights and translational perspectives.Front Immunol2026https://conductscience.org/library/papers/42657027PubMed
42507221Rewiring glucose metabolism in pancreatic cancer by natural compounds: implications for immune evasion and therapeutic targets.Mol Biol Rep2026https://conductscience.org/library/papers/42507221PubMed
42375394Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BC.Mol Ther Oncol2026https://conductscience.org/library/papers/42375394PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
OGT8473PubTator's text mininghttps://conductscience.org/library/genes/8473NCBI Gene
PADI423569PubTator's text mininghttps://conductscience.org/library/genes/23569NCBI Gene
ST6GAL16480PubTator's text mininghttps://conductscience.org/library/genes/6480NCBI Gene
TRBV20OR9-26962PubTator's text mininghttps://conductscience.org/library/genes/6962NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41228299

GET https://conductscience.org/api/papers/v1/41228299/references?page=2